Ashia Everett

Ashia Everett supports the Centers for Disease Control and Prevention’s Office of Acquisition Services in managing critical procurement activities that enable public health infrastructure and scientific response capabilities. She handles complex acquisitions for laboratory diagnostics, biomedical research tools, and data systems essential to disease surveillance and outbreak response. Her work directly advances CDC’s mission by securing high-precision equipment, analytical instruments, and operational services that support national health security. She typically manages full lifecycle contracts under FAR Part 15, with a focus on performance-based requirements for technical and scientific deliverables. Everett maintains longstanding relationships with key contractors including General Dynamics Information Technology, GlaxoSmithKline, MRIGLOBAL, Cepheid, and the New York City Health & Hospitals Corp. These partnerships span high-compliance domains such as infectious disease testing, biosafety-grade laboratory services, and clinical data integration. Her contracting approach emphasizes vendor technical capability, regulatory adherence, and rapid scalability to meet public health emergencies. She routinely engages with both large prime contractors and specialized technical providers to ensure mission-critical capabilities remain resilient and responsive. Her procurement patterns reflect a strong preference for open competition, with 85.7% of awards issued without set-asides, indicating a focus on technical merit and market-wide competition. However, she consistently allocates 14.3% of opportunities to total small business set-asides under FAR 19.5, demonstrating a measured commitment to small business participation without compromising mission requirements. This balance ensures access to innovative solutions while maintaining the scale and expertise needed for national health operations. Everett’s primary NAICS focus is on 334516—Analytical Laboratory Instrument Manufacturing—reflecting deep expertise in procuring PCR systems, sequencing platforms, and diagnostic analyzers. She also routinely acquires services under 811210 for precision equipment maintenance and 325120 for specialized gas systems supporting biosafety labs. Her technical domain spans clinical diagnostics, laboratory automation, and public health data infrastructure, positioning her at the intersection of scientific innovation and federal procurement compliance.